ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies

Genotype-Positive Status in Patients With Hypertrophic Cardiomyopathy Is Associated With Higher Rates of Heart Failure Events

(2014) Q. Li et al.   Circulation-Cardiovascular Genetics

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I

(2013) Hui Wang et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors

(2011) Barry J. Maron et al.   HEART RHYTHM

A method and server for predicting damaging missense mutations

(2010) Ivan A Adzhubei et al.   NATURE METHODS

A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy

(2009) F. W. Friedrich et al.   EUROPEAN HEART JOURNAL

Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy

(2009) Ferrin C. Wheeler et al.   PLoS Genetics